“NIH SMaHT Network Unveils DNA Sequencing Methods to Detect Rare Somatic Mutations Linked t” — what this page in the network covers. The National Institutes of Health's Somatic Mosaicism across Human Tissues (SMaHT) Network has published its first comprehensive benchmarking study in the journal Cell, revealing new DNA sequencing methods capable of detecting rare somatic mutations that accumulate as bodies grow and age. These mutations, which occur in non-reproductive cells, are increasingly recognized not only as drivers of cancer but also as potential seeds of common noncancerous diseases.
The SMaHT Network, a Common Fund initiative, aims to catalog the full spectrum of normal somatic mutation processes across human tissues, providing a foundational resource for understanding how these genetic changes contribute to health and disease. By establishing robust benchmarks for sequencing accuracy and sensitivity, the study enables researchers to reliably identify even low-frequency mutations that may underlie conditions such as cardiovascular disease, neurodegeneration, and immune disorders. The full version stays on the original page, which this listing opens directly.